Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate
Open Access
- 1 September 1998
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatism
- Vol. 41 (9) , 1703-1704
- https://doi.org/10.1002/1529-0131(199809)41:9<1703::aid-art25>3.0.co;2-d
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty‐eight weeks. An open‐label extension studyArthritis & Rheumatism, 1997
- Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprineArthritis & Rheumatism, 1996
- Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid ArthritisNew England Journal of Medicine, 1995
- Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combinationSeminars in Arthritis and Rheumatism, 1993
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Low-dose cyclosporin versus placebo in patients with rheumatoid arthritisThe Lancet, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITISJAMA, 1949